Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus

Microbiology

Volumn 145, Issue 1, 1999, Pages 211-220

  Brennan, F R ^a   Jones, T D ^a   Gilleland, L B ^b   Bellaby, T ^a   Xu, F ^a   North, P C ^a   Thompson, A ^a   Staczek, J ^b   Lin, T ^c   Johnson, J E ^c   Hamilton, W D O ^a   Gilleland Jr , H E ^b  

^a Axis Genetics plc   (United Kingdom)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Chimaeric virus particle; Cowpea mosaic virus; Outer membrane protein F; Pseudomonas aeruginosa; Vaccine

Indexed keywords

COAT PROTEIN; EPITOPE; IMMUNOGLOBULIN G2A; OUTER MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; IMMUNIZATION; MOSAIC VIRUS; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; VIRUS PARTICLE;

ANIMALIA; COWPEA MOSAIC VIRUS; MARTES PENNANTI; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0032921502     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/13500872-145-1-211     Document Type: Article

References (35)

1. Abdillahi, H. & Poolman, J. T. (1987). Whole cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 48, 367-371.
2. Battershill, J. L., Speert, D. P. & Hancock, R. E. W. (1987). Use of monoclonal antibodies to protein F of Pseudomonas aeruginosa as opsonins for phagocytosis by macrophages. Infect Immun 55, 2531-2533.
3. Cooper, P. D. (1994). The selective induction of different immune responses by vaccine adjuvants. In Vaccine Design, pp. 125-158. Edited by G. I. Ada. Austin, TX: R. G. Landes.
4. Cripps, A. W., Dunkley, M. L. & Clancy, R. L. (1994). Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats. Infect Immun 62, 1427-1436.
5. Cripps, A. W., Dunkley, M. L., Taylor, D. C., Cousins, S. & Clancy, R. L. (1995). Immunity to Pseudomonas aeruginosa: induced by OprF following intestinal immunization. In Advances in Mucosal Immunology, pp. 761-763. Edited by J. Mastecky, H. Tlaskalova & J. Steriz. New York: Plenum.
6. Dalsgaard, K., Uttenthal, A., Jones, T. D. & 12 other authors (1997). Plant-derived vaccine protects target animals against a viral disease. Nature Biotecbnol 15, 248-252.
7. Dessens, J. T. & Lomonossoff, G. P. (1993). Cauliflower mosaic virus 35S promoter-controlled DNA copies of cowpea mosaic virus RNAs are infectious on plants. J Gen Virol 74, 889-892.
8. Dunkley, M. L., Cripps, A. W., Reinbott, R. & Clancy, R. L. (1995). Immunity to respiratory Pseudomonas aeruginosa infection: the role of gut-derived T helper cells and immune serum. In: Advances in Mucosal Immunology, pp. 771-775. Edited by J. Mastecky, H. Tlaskalova & J. Steriz. New York: Plenum.
9. Eckhardt, A., Heiss, M. M., Ehret, E., Permanetter, W., Duchene, M., Domdey, H. & von Specht, B.-U. (1991). Evaluation of protective mAbs against Pseudomonas aeruginosa outer membrane protein I by C1q binding assay. Zentbl Bakteriol 275, 100-111.
10. Gilleland, H. E., Jr, Parker. M. G., Matthews, J. M. & Berg, R. D. (1984). Use of purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice. Infect Immun 44, 49-54.
11. Gilleland, H. E., Jr, Gilleland, L. B. & Matthews-Greer, J. M. (1988). Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model. Infect Immun 56, 1017-1022.
12. Gilleland, H. E., Jr, Gilleland, L. B., Hughes, E. E. & Matthews-Greer, J. M. (1992). Recombinant outer membrane protein F of Pseudomonas aeruginosa elicits antibodies that mediate opsonophagocytic killing but not complement-mediated bacteriolysis of various strains of P. aeruginosa. Curr Microbiol 24, 1-7.
13. Gilleland, H. E., Jr, Hughes, E. E., Gilleland, L. B., Matthews-Greer, J. M. & Staczek, J. (1995). Use of synthetic peptides to identify surface-exposed, linear B-cell epitopes within outer membrane protein F of Pseudomonas aeruginosa. Curr Microbiol 31, 279-286.
14. Gilleland, L. B. & Gilleland, H. E., Jr (1995). Synthetic peptides representing two protective, linear B cell epitopes of outer membrane protein F of Pseudomonas aeruginosa elicit whole cell-reactive antibodies that are functionally pseudomonad-specific. Infect Immun 63, 2347-2351.
15. Gotoh, N., Wakebe, H., Yoshihara, E., Nakae, T. & Nishino, T. (1989). Role of protein F in maintaining structural integrity of the Pseudomonas aeruginosa outer membrane. J Bacteriol 171, 983-990.
16. Gupka, R. K. & Siber, G. R. (1995). Adjuvants for human vaccines - current status, problems and future prospects. Vaccine 13, 1263-1276.
17. Hancock, R. E. W., Mutharia, L. M. & Mouat, E. C. A. (1985). Immunotherapeutic potential of monoclonal antibodies against Pseudomonas aeruginosa protein F. J Clin Microbiol 4, 224-227.
18. Huesser, C., Anderson, C. & Grey, H. (1977). Receptors for IgG: subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a mouse macrophage cell line. J Exp Med 145, 1316-1326.
19. Hughes, E. E. & Gilleland, H. E., Jr (1995). Ability of synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa to afford protection against P. aeruginosa in a murine acute pneumonia model. Vaccine 13, 1750-1753.
20. Hughes, E. E., Gilleland, L. B. & Gilleland, H. E., Jr(1992). Synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa that elicit antibodies reactive with whole cells of heterologous immunotype strains of P. aeruginosa. Infect Immun 60, 3497-3503.
21. Kensil, C. R., Patel, U., Lennick, M. & Marciani, D. (1991). Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J Immunol 146, 431-437.
22. Kensil, C. R., Wu, J.-Y. & Soltysik, S. (1995). Structural and immunological characterization of the vaccine adjuvant QS-21. In Vaccine Design: The Subunit and Adjuvant Approach, pp. 525-541. Edited by M. F. Powell & M. J. Newman. New York : Plenum.
23. Klaus, G., Pepys, M., Katajima, K. & Askonas, B. (1979). Activation of mouse complement by different classes of mouse antibody. Immunology 38, 687-695.
24. Kunkel, T. A. (1985). Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 82, 488-496.
25. Lomonossoff, G. P. & Johnson, J. E. (1991). The synthesis and structure of comovirus capsids. Prog Biopbys Mol Biol 55, 107-137.
26. McLain, L., Porta, C., Lomonossoff, G. P., Durrani, Z. & Dimmock, N. J. (1995). Human immunodeficiency virus type 1 neutralizing antibodies raised to a gp41 peptide expressed on the surface of a plant virus. AIDS Res Hum Retrovir 11, 327-334.
27. McLain, L., Durrani, Z., Wisniewski, L. A., Porta, C., Lomonossoff, G. E. & Dimmock, N. J. (1996). Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22-mer amino acid peptide expressed on the surface of a plant virus. Vaccine 14, 799-810.
28. Matthews-Greer, J. M. & Gilleland, H. E., Jr (1987). Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model. J Infect Dis 155, 1282-1291.
29. Matthews-Greer, J. M., Robertson, D. E., Gilleland, L. B. & Gilleland, H. E., Jr (1992). Pseudomonas aeruginosa outer membrane protein F produced in Escherichia coli retains vaccine efficacy. Curr Microbiol 20, 171-175.
30. Natsuume-Sakai, S., Motonishi, K. & Migita, S. (1977). Quantitative estimations of five classes of immunoglobulin in inbred mouse strains. Immunology 32, 861-866.
31. Porta, C., Spall, V. E., Loveland, J. E., Johnson, J. E., Barker, P. J. & Lomonossoff, G. P. (1994). Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides. Virology 202, 949-955.
32. Sandlie, I. & Michaelsen, T. E. (1991). Engineering monoclonal antibodies to determine the structural requirements for complement activation and complement mediated lysis. Mol Immunol 12, 1361-1368.
33. Sherry, B., Mosser, A. G., Colonno, R. J. & Rueckert, R. R. (1986). Use of monoclonal antibodies to identify four neutralisation immunogens on a common cold picornavirus, human rhinovirus 14. J Virol 57, 246-257.
34. von Specht B.-U., Lucking, H. C., Blum, B., Schmitt, A., Hungerer, K. D. & Domdey, H. (1996). Safety and immunogenicity of a Pseudomonas aeruginosa outer membrane protein I vaccine in human volunteers. Vaccine 14, 1111-1117.
35. Usha, R., Rohll, J., Spall, V. E., Shanks, M., Maule, A. J., Johnson, J. E. & Lomonossoff, G. P. (1993). Expression of an animal virus antigen on the surface of a plant virus particle. Virology 197, 366-374.